Navigation Links
PharmAthene Presents Data for SparVax(TM), a Novel Vaccine for the Prevention and Treatment of Anthrax Infection, at the 12th Annual Conference on Vaccine Research
Date:4/28/2009

ANNAPOLIS, Md., April 28 /PRNewswire/ -- PharmAthene, Inc. (NYSE Amex: PIP), a biodefense company developing medical countermeasures against biological and chemical threats, announced today that results from a second Phase II study of SparVax(TM) were presented yesterday at the 12th Annual Conference on Vaccine Research, being held in Baltimore, MD, April 27-29, 2009. The conference is sponsored by the National Foundation of Infectious Diseases.

David P. Wright, President and Chief Executive Officer of PharmAthene commented, "We are very pleased to have had the opportunity to present these latest data for SparVax(TM) at Annual Conference on Vaccine Research. The study, which compared our vaccine to the currently licensed anthrax vaccine, BioThrax(R), provides further confirmation that SparVax(TM) is immunogenic and promotes good immunological recall following antigenic challenge. In addition, a lower incidence of injection site reactions observed with SparVax(TM) may suggest that it is better tolerated than BioThrax(R), a very important finding for this product candidate. Presentation of these data to attendees at this conference allows PharmAthene to continue to increase awareness of the progress we are making developing improved products using modern vaccine technologies to protect our Nation's citizens and military."

SparVax(TM) is a novel second generation recombinant protective antigen (rPA) anthrax vaccine that is being developed for pre and post exposure protection against anthrax infection.

SparVax(TM) Phase II Clinical Data

Results from a Phase II clinical trial of SparVax(TM) were presented during a poster session by Dr. Matthew Duchars, Chief Scientific Officer for PharmAthene.

The study was one of two Phase II trials evaluating different dose and dosing regimens of Sp
'/>"/>

SOURCE PharmAthene, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. PharmAthene Announces $5.5 Million Public Equity Offering
2. PharmAthene To Host Year-End 2008 Earnings Conference Call and Webcast on Monday, March 30, 2009
3. PharmAthene Presents Data for SparVax(TM) and Valortim(R), a Novel Vaccine and Anti-Toxin for the Prevention and Treatment of Anthrax Infection at the 7th Annual ASM Biodefense Meeting
4. PharmAthene Signs Agreement with Medison Pharma Ltd. to Commercialize and Distribute Biodefense Medical Countermeasures in Israel
5. Pharmathene Reports Third Quarter 2008 Financial and Operational Results
6. PharmAthene to Host Third Quarter 2008 Conference Call and Webcast on Thursday, November 13, 2008
7. PharmAthene to Present on Wednesday, November 12th at the 10th Annual Rodman & Renshaw Healthcare Conference
8. Medarex And PharmAthene Announce New Therapeutic Data for Anthrax Anti-Toxin, Valortim(R)
9. PharmAthene and Panacea Biotec Ltd. Establish Strategic Alliance in Biodefense and Emerging Infectious Diseases
10. PharmAthene Awarded NIAID Contract For Up to $83.9 Million For Third Generation rPA Anthrax Vaccine Program
11. PharmAthene to Present Data for Protexia(R) and Valortim(R) at HHS PHEMCE Stakeholders Workshop 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... (PRWEB) July 22, 2014 The next ... September 9th, 2014 and will comprise of the increasingly ... classes. The TechTrainings is a series of technical hands-on ... to help them reach the next step in their ... is taught by Jennifer Kang, Senior Statistician at ...
(Date:7/21/2014)... chemist in Syracuse University,s College of Arts and ... the synthesis of stainless nanoparticles. , Mathew M. ... a three-year, $360,000 grant from the National Science ... with metal stainless alloy nanostructures, the results of ... rechargeable lithium-ion batteries. , Maye,s approach ...
(Date:7/20/2014)... fuel gets recycled, the process releases radioactive krypton and ... with the related gas radon. A new porous material ... July 20 in Nature Materials shows how: ... not out. , The CC3 material could be ... nuclear fuel or air in buildings and also in ...
(Date:7/18/2014)... Researchers at the University of Illinois at Urbana-Champaign ... pillar-bowtie nanoantennas (pBNAs) can be used like traditional ... are much smaller than the wavelength of light ... red light). A standard optical microscope acts as ... film. , "Unlike conventional photographic film, the effect ...
Breaking Biology Technology:Clinovo TechTrainings: Next Session of SAS and CDISC Classes Start 9th September, 2014 2Clinovo TechTrainings: Next Session of SAS and CDISC Classes Start 9th September, 2014 3Syracuse University chemist to use NSF grant to study materials chemistry, nanoscience 2A noble gas cage 2A noble gas cage 3'Nanocamera' takes pictures at distances smaller than light's own wavelength 2
... SHANGHAI, China, April 30 /Xinhua-PRNewswire/ -- Today, ... and NovaSecta in,their CRO Service Alliance CROSA ... companies. Tigermed,s expertise in clinical,development complements the ... the alliance., Sundia Meditech, United PharmaTech, ...
... add ... ... TSX symbol: SBS, CALGARY, April 30 /PRNewswire-FirstCall/ - Botaneco, a wholly-owned,subsidiary ... Croda Enterprise Technology, part of Croda,International Plc, an international manufacturer of speciality ingredients,with ...
... For-Profit Healthcare Companies, EL SEGUNDO, Calif., April ... care services, announced it has been honored for,the ... of the Top 125,ranking companies of employee-sponsored workforce ... that demonstrate a deep,commitment to learning and development ...
Cached Biology Technology:Shanghai CRO Service Alliance Adds Clinical Development Capabilities 2Shanghai CRO Service Alliance Adds Clinical Development Capabilities 3Botaneco signs feasibility agreement with Croda to develop specialty crop oil formulation 2Botaneco signs feasibility agreement with Croda to develop specialty crop oil formulation 3DaVita Honored for 4th Year as Training Top 125 Recipient 2
(Date:7/21/2014)... often results from the strength of immune response, rather ... rather than attacking the virus, might be a better ... the University of Washington, Seattle. She and her collaborators ... that for the H7N9 influenza, and their work has ... this highly virulent strain. The research is published ahead ...
(Date:7/21/2014)... Urban stormwater runoff is causing problems for the ... Environmental Protection Agency found stormwater runoff to be ... environments in rivers, streams, lakes, ponds, reservoirs, bays, ... can harm fish and wildlife populations, foul drinking ... from North Carolina State University are looking to ...
(Date:7/21/2014)... of life are now being developed to try and ... of species. Specifically, a recent model proposed by Petri ... accounts for species interactions with various degrees of symmetry, ... previous, simpler models, which apply random fitness levels to ... demonstrate that the resulting replicator ecosystems do not appear ...
Breaking Biology News(10 mins):Potential new flu drugs target immune response, not virus 2Filter bed substrates, plant types recommended for rain gardens 2Refined biological evolution model 2
... Data publishers should have the option of submitting their ... paper commissioned by the Global Biodiversity Information Facility (GBIF). ... recommendations made by Mark Costello and co-authors in the ... biodiversity data publication , freely available for download ...
... cells from patients with inherited heart muscle disease can ... to patients, including the possibility of testing new treatments ... cell model matches that of the clinical features of ... disease associated with sudden cardiac death Landmark study published ...
... more than 6,000 species of frogs in the world lay ... eggs out of water. This behavior protects the eggs from ... their risk of drying out. Justin Touchon, post-doctoral fellow at ... Panama may be altering frogs, course of evolution. By analyzing ...
Cached Biology News:Peer review option proposed for biodiversity data 2National Heart Centre Singapore develops world's first human heart cell model 2National Heart Centre Singapore develops world's first human heart cell model 3
MMP-1/8 (H-300)...
Gastric Carcinoma Marker [BY-1 (3H11)]...
Mouse VEGF R1/Flt-1 Phycoerythrin MAb (Clone 141522) Keywords: Receptor Tyrosine Kinase, RTK, VEGFR1, VEGF Receptor 1 Protein Family: Receptor Tyrosine Kinases, VEGF/PDGF Family...
Mouse VEGF R1/Flt-1 Allophycocyanin MAb (Clone 141522) Keywords: Receptor Tyrosine Kinase, RTK, VEGFR1, VEGF Receptor 1 Protein Family: Receptor Tyrosine Kinases, VEGF/PDGF Family...
Biology Products: